Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group

Medicine and Dentistry

• Influenza 100%
• Antivirus Agent 66%
• Surveillance 50%
• Polymerase 50%
• Clinical Study 33%
• Sialidase Inhibitor 33%
• Development 16%
• In Vitro 16%
• Virus Infection 16%
• Evaluation Study 16%
• Oseltamivir 16%
• Drug Sensitivity 16%
• Zanamivir 16%
• Severe Acute Respiratory Syndrome Coronavirus 2 16%
• Baloxavir Marboxil 16%
• Assessment 16%
• Laboratory 16%
• Monitoring 16%
• Therapeutic Procedure 16%

INIS

• influenza 100%
• surveillance 50%
• polymerases 50%
• drugs 33%
• evaluation 16%
• laboratories 16%
• animals 16%
• testing 16%
• monitoring 16%
• in vitro 16%
• assessments 16%
• diseases 16%
• reviews 16%
• guidelines 16%
• viruses 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Influenza 100%
• Antivirus Agent 66%
• Drug Combination 33%
• Sialidase Inhibitor 33%
• Virus Infection 16%
• Relenza 16%
• Oseltamivir 16%
• Animal 16%
• Baloxavir Marboxil 16%
• Respiratory Virus 16%